Clinical Trial Update: Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 testing of the MyoScience Tissue Remodeling Device for facial rejuvenation has been completed, sponsored by Pacira Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Rhytides

Drugs mentioned

• MyoScience Tissue Remodeling Device

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Facial Rhytides | Phase 1, Phase 2 | Status: COMPLETED